NeuroVigil Company
%20.jpg)
NeuroVigil is a leading neurotechnology revolutionizing EEG analysis for clinical trials, communication and space applications.
Headquarters:
United States
Funding Status:
N/A
Employee Number:
1-10
Estimated Revenue:
$1M to $10M
Investment Stage:
N/A
Number Of Exists:
N/A
Technology:
Neuropharmacology
Investor Type:
N/A
Founded Date:
2007
Industry:
Space Medicine